Back

ATP-citrate lyase as a therapeutic target in chronic kidney disease: a Mendelian Randomization analysis

2021-10-11 nephrology Title + abstract only
View on medRxiv
Show abstract

BackgroundATP-citrate lyase (ACLY) inhibition is a promising therapeutic target for dyslipidemia, atherosclerotic cardiovascular disease, non-alcoholic steatohepatitis, and metabolic syndrome. Genetic analysis of its role in chronic kidney disease (CKD) has not been performed. MethodsWe constructed a genetic instrument by selecting variants associated with ACLY expression level in the expression quantitative trait loci genetics consortium (eQTLGen) that includes blood samples from 31,684 partic...

Predicted journal destinations